Intervention Review

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema

  1. Mariacristina Parravano1,*,
  2. Francesca Menchini2,
  3. Gianni Virgili3

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 15 APR 2009

DOI: 10.1002/14651858.CD007419.pub2

How to Cite

Parravano M, Menchini F, Virgili G. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD007419. DOI: 10.1002/14651858.CD007419.pub2.

Author Information

  1. 1

    Fondazione G.B. Bietti per lo studio e la ricerca in Oftalmolologia-IRCCS, Ophthalmology, Rome, Italy

  2. 2

    University of Udine, Azienda Ospedaliero-universitaria di Udine, Department of Ophthalmology, Udine, Italy

  3. 3

    University of Florence, Department of Neuro-Oto-Ophthalmological Surgical Sciences, Eye Clinic, Florence, Italy

*Mariacristina Parravano, Ophthalmology, Fondazione G.B. Bietti per lo studio e la ricerca in Oftalmolologia-IRCCS, Via Livenza n 3, Rome, 00198, Italy. criparra@tin.it.

Publication History

  1. Publication Status: New
  2. Published Online: 7 OCT 2009

SEARCH

  1. Current Version

    Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema

    Mariacristina Parravano, Francesca Menchini and Gianni Virgili

    Article first published online: 7 OCT 2009 | DOI: 10.1002/14651858.CD007419.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema

    Mariacristina Parravano and Francesca Menchini

    Article first published online: 8 JUL 2009 | DOI: 10.1002/14651858.CD007419